Global Epigenetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Image

Global Epigenetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4575944
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abcam, Plc.
  • Active Motif, Inc.
  • Diagenode, Inc.
  • Illumina, Inc.
  • Merck & Co., Inc.
  • New England Biolabs, Inc.
  • MORE
Epigenetics Market - Growth, Future Prospects and Competitive Analysis, 2016 - 2026 the global epigenetics market was valued at US$ 4.63 Bn in 2017, and is expected to reach US$ 16.50 Bn by 2026, expanding at a CAGR of 15.03 % from 2018 to 2026.

Market Insights
Epigenetics is a relatively new science in the broader field of genetics, and involves the study of the chemical modification of specific genes or gene-associated proteins. These epigenetic changes do not involve changes in the actual DNA sequence. For the purpose of the study, epigenetics market is segmented into product types such as kits (ChiP-Seq Kits, whole-genome amplification kits, 5-HMC and 5-MC analysis kits and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools. Currently, the demand for kits is highest in the market and anticipated to exhibits fastest market growth over the forecast period. Continuous advancement in the nature and precision of testing kits, rising prevalence of different diseases, wide availability of robust, simple-to-use, and cost-efficient kits, and increasing application of epigenetic technologies in research laboratories are the factors that catalyze the overall market growth.

The global epigenetics market is segmented on the basis of technologies such as DNA methylation, histone modification and other techniques. DNA methylation is most widely accepted technology as it has great potential in the field of personalized drug development and understanding the functional mechanisms in complex disease cases. Epigenetics have application in cancer, metabolic diseases, immune diseases, cardiovascular diseases and other areas. Cancer application held largest market share in the base year 2017, because epigenetic alterations are essential in the cellular transformation to cancer, and their manipulation holds great potential in cancer detection, prevention and therapy.

North America is the current leader in global epigenetics market and expected to show dominance over the forecast period. Higher acceptance of newer technologies, enormous investment in R&D, and developed healthcare infrastructure are the key factors contributing to the dominance of this region. On the other hand, Asia Pacific is projected to show fastest market growth over the forecast period primarily due to increasing healthcare spending and developing healthcare infrastructure. Significant CRO activities in hubs such as India also feature the rapid pace of Asia Pacific market.

Market Competition Assessment:
The epigenetics market is highly competitive owing to the presence of market players across geographies with investments in research activities. The market currently is dominated by few key manufacturers such as Abcam, Plc., Active Motif, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Diagenode, Inc., Illumina, Inc., Merck & Co., Inc., New England Biolabs Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corp. and others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcam, Plc.
  • Active Motif, Inc.
  • Diagenode, Inc.
  • Illumina, Inc.
  • Merck & Co., Inc.
  • New England Biolabs, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Epigenetics Market Portraiture
2.2. Global Epigenetics Market, by Product, 2017 (US$ Mn)
2.3. Global Epigenetics Market, by Technology, 2017 (US$ Mn)
2.4. Global Epigenetics Market, by Application, 2017 (US$ Mn)
2.5. Global Epigenetics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Epigenetics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Opportunities
3.3. Attractive Investment Proposition: Epigenetics Market, by Geography, 2017
3.4. Competitive Analysis of Key Players in Epigenetics Market, 2017

Chapter 4. Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Kits
4.2.1. ChiP-Seq Kits
4.2.2. Whole-Genome Amplification Kits
4.2.3. 5-HMC and 5-MC Analysis Kits
4.2.4. Other Epigenetics Kits
4.3. Reagents
4.4. Enzymes
4.4.1. DNA-Modifying Enzymes
4.4.2. Protein-Modifying Enzymes
4.4.3. RNA-Modifying Enzymes
4.5. Instruments
4.6. Bioinformatics Tools

Chapter 5. Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. DNA Methylation
5.3. Histone Modification
5.4. Other Techniques

Chapter 6. Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Cancer
6.3. Metabolic Diseases
6.4. Immune Diseases
6.5. Cardiovascular Diseases
6.6. Others

Chapter 7. Global Epigenetics Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America Epigenetics Market, 2016 – 2026 (US$ Mn)
7.2.1. North America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.2.3. North America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.2.4. North America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Epigenetics Market, 2016 – 2026 (US$ Mn)
7.3.1. Europe Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.3.2. Europe Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.3.3. Europe Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.3.4. Europe Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Epigenetics Market, 2016 – 2026 (US$ Mn)
7.4.1. Asia Pacific Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of APAC
7.5. Latin America Epigenetics Market, 2016 – 2026 (US$ Mn)
7.5.1. Latin America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.5.2. Latin America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.5.3. Latin America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.5.4. Latin America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Epigenetics Market, 2016 – 2026 (US$ Mn)
7.6.1. Middle East and Africa Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.6.2. Middle East and Africa Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.6.3. Middle East and Africa Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.6.4. Middle East and Africa Epigenetics Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abcam, Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Type Portfolio
8.1.4. Key Developments
8.2. Active Motif, Inc.
8.3. Agilent Technologies, Inc.
8.4. Bio-Rad Laboratories, Inc.
8.5. Diagenode, Inc.
8.6. Illumina, Inc.
8.7. Merck & Co., Inc.
8.8. New England Biolabs, Inc.
8.9. Perkinelmer, Inc.
8.10. Qiagen N.V.
8.11. Thermo Fisher Scientific, Inc.
8.12. Zymo Research Corp.

List of Figures
FIG. 1 Epigenetics: Market Segmentation
FIG. 2 Global Epigenetics Market, by Product, 2017 (US$ Mn)
FIG. 3 Global Epigenetics Market, by Technology, 2017 (US$ Mn)
FIG. 4 Global Epigenetics Market, by Application, 2017 (US$ Mn)
FIG. 5 Global Epigenetics Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2017
FIG. 8 Global ChiP-Seq Kits Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Whole-Genome Amplification Kits Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global 5--HMC and 5-MC Analysis Kits Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Other Epigenetics Kits Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Reagents Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 13 Global DNA Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Protein Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 15 Global RNA Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 16 Global Instruments Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 17 Global Bioinformatics Tools Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 18 Global DNA Methylation Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 19 Global Histone Modification Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 20 Global Other Techniques Market for Epigenetics in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 21 Global Epigenetics Market for Cancer, 2016 – 2026 (US$ Mn)
FIG. 22 Global Epigenetics Market for Metabolic Diseases, 2016 – 2026 (US$ Mn)
FIG. 23 Global Epigenetics Market for Immune Diseases, 2016 – 2026 (US$ Mn)
FIG. 24 Global Epigenetics Market for Cardiovascular Diseases, 2016 – 2026 (US$ Mn)
FIG. 25 Global Epigenetics Market for Other Applications, 2016 – 2026 (US$ Mn)
FIG. 26 U.S. Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 27 Canada Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 28 U.K. Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 29 Germany Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Europe Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 31 Japan Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 32 China Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest of Asia Pacific Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 34 Brazil Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 35 Mexico Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 36 Rest of Latin America Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 37 GCC Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 38 Rest of Middle East and Africa Epigenetics Market, 2016 – 2026 (US$ Mn)

List of Tables
TABLE 1 Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 3 Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 North America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 North America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 6 North America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 Europe Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East and Africa Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East and Africa Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 24 Abcam, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 25 Active Motif, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 26 Agilent Technologies, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 27 Bio-Rad Laboratories, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 28 Diagenode, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 29 Illumina, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 30 Merck & Co., Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 31 New England Biolabs, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 32 Perkinelmer, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 33 Qiagen N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 34 Thermo Fisher Scientific, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 35 Zymo Research Corp. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abcam, Plc.
  • Active Motif, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Diagenode, Inc.
  • Illumina, Inc.
  • Merck & Co., Inc.
  • New England Biolabs, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corp.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll